News & Insights
Sort By
Insights 326 Results
Insights
|February 19, 2026
Law360 Interviews Stephanie Goutos in "Meet The Attys 'Vibe-Coding' Their Own AI Apps"
Gunderson Dettmer partner and head of employment law practice innovation Stephanie Goutos is interviewed for Law360's article, "Meet The Attys 'Vibe-Coding' Their Own AI Apps."
Insights
|February 11, 2026
The deadline for making certain initial, annual and amended securities filings for the year ended December 31, 2025 is Tuesday, February 17, 2026
Insights
|February 5, 2026
2026 AI Laws Update: Key Regulations and Practical Guidance
This client alert provides a high-level overview of key AI laws enacted or taking effect in 2026
Events 114 Results
Events
|February 11, 2026
Webinar: 2026 Employment Law Update
This briefing helps founders, HR leaders, and in-house counsel prioritize what matters most for the year ahead
Events
|January 27, 2026
Tim Ehrlich, Chair of Gunderson Dettmer’s Life Sciences practice and host of the “What’s Next in Biotech” series, sits down with Hogan Lovells Partner and former senior FDA official Elizabeth Jungman for a candid conversation about where biotech regulatory pathways stand today and where they are headed next.
Events
|January 22, 2026
Employment & Labor Partner Max Perlman is the chair of MCLE’s upcoming seminar “Employment Law for Business Lawyers & In-House Counsel” and will be presenting on developments in noncompete law and navigating the current Administration’s impact on labor and employment law
Client News 1,538 Results
Client News
|February 26, 2026
Third Way Health Announces $15 Million Series A
Leading AI-enabled services partner for healthcare organizations, Third Way Health, announces its $15 million Series A financing by Health Velocity Capital.
Client News
|February 25, 2026
Elly Launches With $8 Million Pre-Seed Financing
Elly announces the launch of its AI-native hiring platform and concurrent $8 million pre-seed financing led by Sorenson Capital, with participation from Atomic and Next Wave Capital.
Client News
|February 25, 2026
Gunderson Dettmer Advises Vir Biotechnology on Underwritten Public Offering
Vir Biotechnology announces its underwritten public offering of 20,294,117 shares of common stock at $8.50 per share, including the exercise in full of the underwriters’ option to purchase additional shares.
Firm News 278 Results
Firm News
|March 3, 2026
Gunderson Dettmer Again Named #1 VC Law Firm Worldwide in PitchBook’s 2025 Global League Tables
Gunderson Dettmer is ranked as the most active venture capital law firm globally in PitchBook’s 2025 Annual Global League Tables, marking the 12th consecutive year the firm has earned the top spot since the rankings were introduced and reinforcing its role as the most trusted advisor to investors and companies at every stage. Across venture financings, M&A, and private equity transactions combined, PitchBook also ranks Gunderson as the #1 law firm globally for total deal activity, as well as a top firm for late-stage deals.
Firm News
|February 1, 2026
Gunderson Dettmer Commemorates 2026 Black History Month
Gunderson Dettmer commemorates Black History Month in February 2026 with a series of events across its US offices, access to resources, and a tribute to this month’s theme, "A Century of Black History Commemorations."
Firm News
|January 29, 2026
The Legal 500 ranked thirteen Gunderson Dettmer partners across multiple offices in its US City Elite 2026 edition, highlighting top legal talent in cities throughout the United States.
Blog Posts 58 Results
Public Ventures
|February 17, 2026
“Under my leadership, there is an open-door policy in the Division. I invite companies, investors, and other market participants to tell us what’s working and what’s not, and where there are issues, please propose a solution. The Division is ready to usher in a new day for public companies and their investors. We need your ideas, suggestions, comments, and data to get there. Help us help you!”
Public Ventures
|February 2, 2026
‘A New Day at the PCAOB’: Retired Big Four Audit Partner to Helm Reconstituted Board
Trump administration officials among other new appointees, signaling a coming industry-friendly shift in the audit regulator’s priorities and objectives
Public Ventures
|January 14, 2026
Separating the Wheat from the Chaff: SEC to Undertake Comprehensive Review of Regulation S-K
Public input invited through April 13, 2026 on how to help reduce the volume of immaterial disclosure
